Aarti Industries to return Rs 96 cr to shareholders via buyback

artiSpeciality Chemicals company Aarti Industries Ltd said it will buy back12 lakh equity shares at Rs 800 each, aggregating to Rs 96 cr.

The company´s Board of Directors approved the equity shares — representing up to 1.44% of the company’s base.

“The public announcement setting out the process, timelines and other requisite detail will be released in due course in accordance with the Buyback Regulations,” said the company.

Rashesh Gogri, Vice Chairman & M.D., Aarti Industries said, “The company’s strong balance sheet and cash flows enable us to simultaneously reward the shareholders, while continuing to invest in growth opportunities that will further strengthen our operations and drive long-term profitable growth.”

Aarti Industries (AIL) is an Indian benzene-based speciality chemical company headquartered in Mumbai, Maharashtra, India.

AIL started in 1975, has 125+ products, 500+ domestic customers and 150+ export customers spread across the globe in 60 countries.

AIL serves leading consumers across the globe of Speciality Chemicals and Intermediate for Pharmaceuticals, Agro Chemicals, Polymers, Pigments, Printing Inks, Dyes, Fuel additives, Aromatics, Surfactants and various other speciality chemicals.

The company has 4 Zero Discharge units and a strong focus on Reduce-Reuse-Recover across its 16 manufacturing sites.


PayTM adds support for UPI payments Customers of PayTM, India's largest wallet service can now make payments using the Unified Payments Interface, the government of India's open payments platform.The company has signed up with ICICI Bank be able to receive payments from its customers who are on the UPI platform...
Cipla redraws Iran plans with new agreement, to invest Rs 121 cr Cipla said its wholly owned subsidiary of the Company in Netherlands will set up a 75% joint venture with Ahran Tejarat Company for manufacturing and marketing of pharmaceutical products in Iran.An earlier agreement executed by the Company with the Iranian firm has been termi...
Muthoot Group offers online Will generation facility under tie-up with WillJini The Muthoot Group said its broking and wealth management division, Muthoot Securities Limited, launched iWill -- a service which offers online will writing in just 30 minutes.Muthoot Securities has launched this product in association with WillJini Succession Services Private...
Bliss GVS Healthcare wins three-year contract worth Rs 760 cr from Kenya Bliss GVS Healthcare Ltd said it won a three year contract worth $111.40 mln (Rs 760 cr) from Aon Kenya Insurance Brokers Ltd for provision of medical health care services in Kenya. Bliss GVS Pharma Ltd is a pharmaceutical company based in Mumbai, India.Bliss GVS...
Alembic Pharmaceuticals receives FDA approval for hypertension tablets Alembic Pharmaceuticals Ltd said it received approval from the United States Food & Drug Administration for its abbreviated new drug application for Telmisartan and Amlodipine tablets for hypertension.The Telmisartan and Amlodipine Tablets are equivalent to the Twynsta ta...
Infosys invests Rs 14.5 cr in Danish artificial intelligence startup UNSILO Technology services provider Infosys said it made an investment of 14.92 mln Danish kroners in Danish startup UNSILO from its innovation fund.UNSILO is a Danish artificial intelligence startup founded in 2012 and focus on advanced text analysis.It uses a combination of m...
Lupin launches injectable iron formulations in India Pharma major Lupin Limited said it launched Iron Isomaltoside injectable iron formulation under two brand names “Isofer” and “Jilazo” in India.Lupin acquired the exclusive rights to market, distribute and sell the injectable formulation from Denmark based Pharmacosmos A/S.The...
Dr Reddy’s Labs launches osteoporosis drug in the US Dr Reddy's Laboratories Ltd said it launched raloxifene hydrochloride tablets --used to treat osteoporosis -- in the US market.Raloxifene hydrochloride tablets are a therapeutic equivalent generic version of Evista (raloxifene hydrochloride) tablets. A generic drug is a pharm...
Currency Crunch: Razorpay offers to onboard merchants in 1 hour Online Payment platform Razorpay said it launched a new feature --Express Activation-- in India that promises one-hour activation of new merchant accounts.Razorpay is a payments platform that allows merchants to receive payments via their websites or mobile apps. It helps bus...
Axis Bank adds augmented reality to mobile app Axis Bank said it added an augmented reality-based feature on its Mobile App that will enable home seekers to search and locate properties which are pre-approved by the bank for financing.Jagdeep Mallareddy, Head Retail Lending, Axis Bank, said, “The new augmented reality fea...
United Bank to raise up to Rs 300 cr from LIC United Bank of India said it is allotting equity worth up to Rs 300 cr to Life Insurance Corporation of India.United Bank of India is an Indian government-owned financial services company headquartered in Kolkata, West Bengal, India.Life Insurance Corporation of India is ...
Sun Pharma to get dengue vaccine technology from ICGEB Pharma major Sun Pharma said it tied up with research organization International Centre for Genetic Engineering and Biotechnology to develop vaccines for dengue.The vaccine is targeted against all the four serotypes of Dengue virus that cause disease in humans and is being de...
NPA Crunch: Lypsa Gems repays Rs 7.5 cr to Bank of India, sets an example Lypsa Gems and Jewellery Ltd said it reduced its secured debt by 25% by repaying a loan of Rs 75 mn to Bank of India.As of today, its debt stands at Rs 235 mn, down from Rs 31O mn as of 31st March 2016, it said. Debt Equity Ratio has dropped from 1.03x to 0.75x.Lypsa is...
Marksans Pharma gets USFDA approval for synthetic Vitamin D tablets Marksans Pharma Ltd said the United States Food & Drug Administration has given its approval for its paricalcitol capsules -- a synthetic equivalent of Vitamin D.Vitamin D is important for the absorption of Calcium from the stomach and for the functioning of Calcium in t...
India overdependent on China for medicines – study India may have emerged as a key supplier of generic and affordable medicine for the world market, but it has an "overwhelming dependence" on China for the raw material required to produce these drugs, industry association Assocham said.Indian companies depend on China to supp...
Yes Bank unveils Aadhaar-powered billing machine for small companies Yes Bank has introduced a new billing machine for small businesses tying together Card & UPI payments, Aadhaar E-KYC and Aadhaar E-signing on a ready-to-use basis.This will help small and medium businesses to do their billing and accept payments and also disburse small lo...
US Govt agency to help disburse loans to Indian SMEs RBL Bank and NeoGrowth Credit Pvt will provide loans to small and medium enterprises in the Indian retail segment that are excluded from mainstream funding and financing with the help of a US government agency.The funding will be backed by the Overseas Private Investment ...
Fortis Healthcare to take loan of Rs 77.6 cr from Singapore bank Fortis Healthcare said it´s Mauritius subsidiary Fortis Healthcare international Ltd, has will take a loan of SGD 165 mln (Rs 77.6 crore) from Singapore-based Consortium of Bankers."Fortis Healthcare Ltd has being holding the company, is giving guarantee on behalf of FHIL sec...
Lupin licenses taste-masking technology from Monosol for paediatric tablets Pharma Major Lupin Ltd. said its US subsidiary, Lupin Pharmaceutical Inc., has agreed to license technology from Monosol Rx to develop multiple paediatric-focused products.Lupin would develop the pediatric products utilizing MonoSol Rx’s proprietary PharmFilm drug delivery ...
TechProcess to enable e-payment for Muthoot Finance loans Muthoot Finance, one of India’s largest gold finance company said it has partnered with a Indian electronic payments company TechProcess Payment Services whereby their customers will be able to repay EMI's through a digital platform.The platform powered by powered by TechPr...
Cadila to launch immunosuppressant drug in India Cadila Healthcare, a Ahmedabad headquartered pharmaceutical company owned by Zydus Group, said it has partnered with Switzerland-based global biopharmaceutical company Neovii to launch an drug to reduce the strength of the body's immune system in India.The drug named Grafalon...
Repco Home Finance raises Rs 100 cr by private placement Repco Home Finance Ltd said it raised Rs 100 crore through private placement by allotting 1,000 non-convertible debentures.The face value of the secured redeemable non-convertible debentures are Rs 10 lakh each.Repco Home Finance Ltd (RHFL) is a housing finance company he...
Canara Bank chosen partner for India’s Higher Education Financing Agency Canara bank said it has been chosen as the joint venture partner by the government of India for the establishment of a Higher Education Financing Agency.The Higher Education Financing Agency or HEFA is a not-for-profit agency with initial capital base of Rs. 1000 Crore and w...
Almebic Pharmaceuticals receives inspection report from USFDA Alembic Pharmaceuticals Ltd., said it received an Establishment Inspection Report from the United States Food and Drug Administration for the inspection carried out at their formulation facility at Panelav, Gujarat.The FDA has the authority to inspect any establishment in whi...
Shilpa Medicare receives USFDA approval for generic bone marrow drug Shilpa Medicare Ltd said it received an approval from the United states Food & Drug Administration for Azacitidine injection.Azacitidine is used to treat myelodysplastic syndrome - a group of conditions in which the bone marrow produces blood cells that are misshapen and ...